Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24945893
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Academic medical product development: an emerging alliance of technology transfer
organizations and the CTSA
#MMPMID24945893
Rose LM
; Everts M
; Heller C
; Burke C
; Hafer N
; Steele S
Clin Transl Sci
2014[Dec]; 7
(6
): 456-64
PMID24945893
show ga
To bring the benefits of science more quickly to patient care, the NIH National
Center Advancing Translational Sciences (NCATS) supports programs that enhance
the development, testing, and implementation of new medical products and
procedures. The NCATS clinical and translational science award (CTSA) program is
central to that mission; creating an academic home for clinical and translational
science and supporting those involved in the discovery and development of new
health-related inventions. The technology transfer Offices (TTO) of CTSA-funded
universities can be important partners in the development process; facilitating
the transfer of medical research to the commercial sector for further development
and ultimately, distribution to patients. The Aggregating Intellectual Property
(IP) Working Group (AWG) of the CTSA public private partnerships key function
committee (PPP-KFC) developed a survey to explore how CTSA-funded institutions
currently interface with their respective TTOs to support medical product
development. The results suggest a range of relationships across institutions;
approximately half have formal collaborative programs, but only a few have
well-connected programs. Models of collaborations are described and provided as
examples of successful CTSA/TTO partnerships that have increased the value of
health-related inventions as measured by follow-on funding and industry
involvement; either as a consulting partner or licensee.